We are live on ! Find out more
MOLN

Molecular Partners
MOLN

8 hedge funds and large institutions have $27.6M invested in Molecular Partners in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $22.4M → $27.6M (+$5.21M)

0.59% more ownership

Funds ownership: 3.6% → 4.19% (+0.59%)

11% less funds holding

Funds holding: 9 → 8 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$5.38M
2
Morgan Stanley
Morgan Stanley
New York
+$8.91K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$7.28K

Top Sellers

Rank Fund Capital Flow
1
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$288K
2
Millennium Management
Millennium Management
New York
-$204K
3
UBS Group
UBS Group
Switzerland
-$67.9K
4
Jane Street
Jane Street
New York
-$44K
5
WCMNY
Westchester Capital Management (New York)
New York
-$20K

MOLN Hedge Fund Activity: Q1 2022 in Review

8 of the 6,359 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q1 2022, worth a combined $27.6M — up 23% from $22.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of MOLN and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Federated Hermes, adding an estimated $5.38M. The largest seller was Tudor Investment Corp, exiting entirely with an estimated $288K sold.

  • 8 institutional investors held Molecular Partners (MOLN) as of Q1 2022, down from 9 in Q4 2021.
  • Funds reported $27.6M of Molecular Partners stock for Q1 2022, up 23% quarter-over-quarter.
  • 2 funds opened new Molecular Partners positions in Q1 2022 and 3 closed out, a net change of -1 holder.
  • The largest Molecular Partners buyer in Q1 2022 was Federated Hermes, an estimated $5.38M added.
  • The largest Molecular Partners seller in Q1 2022 was Tudor Investment Corp, an estimated $288K sold.

Based on aggregated 13F filings for Q1 2022.